TY - JOUR
T1 - Innovative 2-Step Management Strategy Utilizing EXIT Procedure for a Fetus With Hypoplastic Left Heart Syndrome and Intact Atrial Septum
AU - Said, Sameh M.
AU - Qureshi, Muhammad Yasir
AU - Taggart, Nathaniel W.
AU - Anderson, Heather N.
AU - O'Leary, Patrick W.
AU - Cetta, Frank
AU - Alrahmani, Layan
AU - Cofer, Shelagh A.
AU - Segura, Leal G.
AU - Pike, Roxann B.
AU - Sharpe, Emily E.
AU - Derleth, Douglas P.
AU - Nemergut, Michael E.
AU - Van Dorn, Charlotte S.
AU - Gleich, Stephen J.
AU - Rose, Carl H.
AU - Collura, Christopher A.
AU - Ruano, Rodrigo
N1 - Publisher Copyright:
© 2018 Mayo Foundation for Medical Education and Research
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/2
Y1 - 2019/2
N2 - Hypoplastic left heart syndrome (HLHS) with intact atrial septum (HLHS-IAS) carries a high risk of mortality and affects about 6% of all patients with HLHS. Fetal interventions, postnatal transcatheter interventions, and postnatal surgical resection have all been used, but the mortality risk continues to be high in this subgroup of patients. We describe a novel, sequential approach to manage HLHS-IAS and progressive fetal hydrops. A 28-year-old, gravida 4 para 2 mother was referred to Mayo Clinic for fetal HLHS. Fetal echocardiography at 28 weeks of gestation demonstrated HLHS-IAS with progressive fetal hydrops. The atrial septum was thick and muscular with no interatrial communication. Ultrasound-guided fetal atrial septostomy was performed with successful creation of a small atrial communication. However, fetal echocardiogram at 33 weeks of gestation showed recurrence of a pleural effusion and restriction of the atrial septum. We proceeded with an Ex utero Intrapartum Treatment (EXIT) delivery and open atrial septectomy. This was performed successfully, and the infant was stabilized in the intensive care unit. The infant required venoarterial extracorporeal membrane oxygenator support on day of life 1. The patient later developed hemorrhagic complications, leading to his demise on day of life 9. This is the first reported case of an EXIT procedure and open atrial septectomy performed without cardiopulmonary bypass for an open-heart operation and provides a promising alternative strategy for the management of HLHS-IAS in select cases.
AB - Hypoplastic left heart syndrome (HLHS) with intact atrial septum (HLHS-IAS) carries a high risk of mortality and affects about 6% of all patients with HLHS. Fetal interventions, postnatal transcatheter interventions, and postnatal surgical resection have all been used, but the mortality risk continues to be high in this subgroup of patients. We describe a novel, sequential approach to manage HLHS-IAS and progressive fetal hydrops. A 28-year-old, gravida 4 para 2 mother was referred to Mayo Clinic for fetal HLHS. Fetal echocardiography at 28 weeks of gestation demonstrated HLHS-IAS with progressive fetal hydrops. The atrial septum was thick and muscular with no interatrial communication. Ultrasound-guided fetal atrial septostomy was performed with successful creation of a small atrial communication. However, fetal echocardiogram at 33 weeks of gestation showed recurrence of a pleural effusion and restriction of the atrial septum. We proceeded with an Ex utero Intrapartum Treatment (EXIT) delivery and open atrial septectomy. This was performed successfully, and the infant was stabilized in the intensive care unit. The infant required venoarterial extracorporeal membrane oxygenator support on day of life 1. The patient later developed hemorrhagic complications, leading to his demise on day of life 9. This is the first reported case of an EXIT procedure and open atrial septectomy performed without cardiopulmonary bypass for an open-heart operation and provides a promising alternative strategy for the management of HLHS-IAS in select cases.
UR - http://www.scopus.com/inward/record.url?scp=85060728494&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060728494&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2018.08.004
DO - 10.1016/j.mayocp.2018.08.004
M3 - Article
C2 - 30711131
AN - SCOPUS:85060728494
SN - 0025-6196
VL - 94
SP - 356
EP - 361
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 2
ER -